Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Lymphedema Imaging and AI: A Review of Diagnostic Modalities, Biomarkers, and Clinical Integration.

PMID: 41271017 · 2025

JournalBiomedical journal
Year2025
PMID41271017

Abstract

Lymphedema, a chronic lymphatic disorder characterized by swelling, fibrosis, and adipose tissue accumulation, requires precise, stage-specific imaging for effective diagnosis and management. This review evaluates conventional imaging modalities, including indocyanine green lymphography (ICG-L), lymphoscintigraphy, magnetic resonance imaging (MRI), and computed tomography (CT), alongside emerging artificial intelligence (AI) applications to enhance diagnostic accuracy and treatment planning. We

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.